
ankylosing spondylitis

Amid tough competition, Novartis makes case for rheumatology drug Cosentyx
Swiss pharma hopes to bounce back from Q1 sales disappointment
X
Amid tough competition, Novartis makes case for rheumatology drug Cosentyx
https://pharmaphorum.com/news/novartis-eric-hughes-cosentyx-secukinumab/

X
Lilly aims for new indication for Taltz
https://pharmaphorum.com/news/eli-lilly-aims-new-indication-il-17-drug-taltz/